Skip to main content
SpringerLink
Log in

Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The aim of this study was to assess the effectivity of the identification of patients with congenital adrenal hyperplasia (CAH) in Hungary in the absence of systematic neonatal screening and to estimate the incidence. Dried blood-spot samples of patients clinically suspected at any age to have CAH were collected between 1978 and 1998 throughout the whole country. 17-Hydroxyprogesterone (17-OHP) was measured by radioimmunoassay. Age-specific cut-offs were used. The effectivity of the system was retrospectively assessed. Additional cases were sought to assess the overall incidence of CAH in Hungary. Among the 1,837 patients investigated, 185 cases of CAH were identified. The overall effectivity was 94.7%. The sensitivity and the specificity were 98.9% and 94.2%, respectively. Salt-wasting (SW) boys were, on average, diagnosed 2 weeks later than SW girls, while both boys and girls with the simple virilising (SV) form were diagnosed at similar ages (2 versus 2.5 years). An additional 19 cases were diagnosed during the study period using other methods (plasma and urinary steroid profiles without blood-spot 17-OHP measurements). The incidence of classical CAH in Hungary was 1:14,300 (CI 95% between 1:12,450 and 1:16,795). Presuming that the incidence of CAH is the same among boys and girls, one can calculate that the diagnosis was missed in 24 boys (2 SW, 22 SV). Conclusion: it is possible to identify the vast majority of classical cases of congenital adrenal hyperplasia without a neonatal mass screening programme. However, a significant number of boys with the simple virilising form missed whereas both salt-wasting boys and girls are diagnosed safely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

CAH :

congenital adrenal hyperplasia

11β-OHD :

11β-hydroxylase deficiency

21-OHD :

21-hydroxylase deficiency

17-OHP :

17-hydroxyprogesterone

NCAH :

non-classical congenital adrenal hyperplasia

RIA :

radioimmunoassay

SV :

simple virilising

SW :

salt-wasting

References

  1. Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F (1996) Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980–1995. Pediatrics 98: 362–367

    CAS  PubMed  Google Scholar 

  2. Brosnan CA, Brosnan P, Therrell BL, Slater CH, Swint JM, Annegers JF, Riley WJ (1998) A comparative cost analysis of newborn screening for classical congenital adrenal hyperplasia in Texas. Public Health Reports 113: 170–178

    CAS  Google Scholar 

  3. Brosnan PG, Brosnan CA, Kemp SF, Domek DB, Jelley DH, Blackett PR, Riley WJ (1999) Effect of newborn screening for congenital adrenal hyperplasia. Arch Dis Pediatr Adolesc Med 153: 1272–1278

    CAS  Google Scholar 

  4. Donaldson MD, Thomas PH, Love JG, Murray GD, McNich AW, Savage DC (1994) Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency. Arch Dis Child 70: 214–218

    CAS  PubMed  Google Scholar 

  5. Ferenczi A, Garami M, Kiss E, Pék M, Sasvári-Székely M, Barta C, Staub M, Sólyom J, Fekete G (1999) Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 84: 2369–2372

    CAS  PubMed  Google Scholar 

  6. Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H and the MEWPE-CAH study group (2001) Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Horm Res 55: 161–171

    Article  CAS  PubMed  Google Scholar 

  7. Homoki J, Sólyom J, Teller WM (1988) Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents. Eur J Pediatr 147: 257–262

    CAS  PubMed  Google Scholar 

  8. Homoki J, Sólyom J, Wachter U, Teller WM (1992) Urinary excretion of 17-hydroxypregnanolones in patients with different forms of congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Eur J Pediatr 151: 24–28

    CAS  PubMed  Google Scholar 

  9. Honour JW, Torresani T (2001) Evaluation of neonatal screening for congenital adrenal hyperplasia. Horm Res 55: 206–211

    Article  CAS  PubMed  Google Scholar 

  10. Joint ESPE/LWPES CAH working group (2002) Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 58: 188–195

    Article  PubMed  Google Scholar 

  11. Kovács J, Votava F, Heinze G, Sólyom J, Lebl J, Pribilincová Z, Frisch H, Battelino T, Waldhauser F (2001) Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five Middle European countries. J Clin Endocrinol Metab 86: 2958–2964

    PubMed  Google Scholar 

  12. Kwon C, Farrell PM (2000) The magnitude of false-positive newborn screening test results. Arch Pediatr Adolesc Med 154: 714–718

    CAS  PubMed  Google Scholar 

  13. Pang S, Shook MK (1997) Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr 9: 419–423

    CAS  PubMed  Google Scholar 

  14. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI (1977) Microfilter paper method for 17-hydroxyprogesterone radioimmunoassay, its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45: 1003–1008

    CAS  PubMed  Google Scholar 

  15. Sólyom J (1981) Blood-spot 17α-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia. Clin Endocrinol 14: 547–553

    Google Scholar 

  16. Sólyom J, Hughes IA (1989) Value of selective screening for congenital adrenal hyperplasia in Hungary. Arch Dis Child 64: 338–342

    PubMed  Google Scholar 

  17. Sólyom J, Hammond GL, Vihko R (1979) A method for identification and follow-up of patients with a steroid-21-hydroxylase deficiency. Clin Chim Acta 92: 117–124

    Article  PubMed  Google Scholar 

  18. Sólyom J, Rácz K, Péter F, Homoki J, Sippel WG, Peter M (2001) Clinical, hormonal and molecular genetic characterization of Hungarian patients with 11β-hydroxylase deficiency. J Endocrine Genet 2: 37–44

    Google Scholar 

  19. Therrell BL (2001) Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30: 15–30

    CAS  PubMed  Google Scholar 

  20. Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101: 583–590

    PubMed  Google Scholar 

  21. Thilén A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larsson A (1998) Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 101: 694

    Google Scholar 

  22. Van der Kamp HJ, Noordam K, Elvers B, Van Baarle M, Otten BJ, Verkerk PH (2001) Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics 108: 1320–1324

    PubMed  Google Scholar 

  23. Virdi NK, Rayner PHW, Rudd BT, Green A (1987) Should we screen for congenital adrenal hyperplasia? A review of 117 cases. Arch Dis Child 62: 659–662

    CAS  PubMed  Google Scholar 

  24. Votava F, Török D, Kovács J, Möslinger D, Sólyom J, Pribilincova Z, Battelino T, Lebl J, Frisch H, Waldhauser F for the MEWPE-CAH (2002) Estimation of the false negative rate in the newborn screening of congenital adrenal hyperplasia. Horm Res 58[Suppl 2]: 98

  25. White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21: 245–291

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by ETT grant (296/2000) and OTKA grants (T-037559 and T-025178).

Author information

Authors and Affiliations

  1. 2nd Department of Paediatrics, Faculty of Medicine, Semmelweis University, Tüzoltó u. 7–9, 1094 , Budapest, Hungary

    Dóra Török, Gudrun Eckhardt & János Sólyom

Authors
  1. Dóra Török
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gudrun Eckhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. János Sólyom
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to János Sólyom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Török, D., Eckhardt, G. & Sólyom, J. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary. Eur J Pediatr 162, 844–849 (2003). https://doi.org/10.1007/s00431-003-1311-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-003-1311-y

Keywords

Search

Navigation